Microbot Medical Inc. (MBOT)
USD 0.97
(-3.69%)
USD 0.97
(-3.69%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -106 Thousand USD | -3.92% |
| 2022 | -102 Thousand USD | -34.21% |
| 2021 | -76 Thousand USD | -11.76% |
| 2020 | -68 Thousand USD | 19.05% |
| 2019 | -84 Thousand USD | -55.56% |
| 2018 | -54 Thousand USD | -157.14% |
| 2017 | -21 Thousand USD | -110.0% |
| 2016 | -10 Thousand USD | -110.0% |
| 2015 | 100 Thousand USD | -90.12% |
| 2014 | 1.01 Million USD | 14.09% |
| 2013 | 887 Thousand USD | -19.71% |
| 2012 | 1.1 Million USD | 9.82% |
| 2011 | 1 Million USD | -20.07% |
| 2010 | 1.25 Million USD | 72.07% |
| 2009 | 731.42 Thousand USD | 215.64% |
| 2008 | 231.73 Thousand USD | 308.54% |
| 2007 | 56.72 Thousand USD | -38.91% |
| 2006 | 92.85 Thousand USD | -54.91% |
| 2005 | 205.91 Thousand USD | 46.0% |
| 2004 | 141.03 Thousand USD | -48.42% |
| 2003 | 273.43 Thousand USD | -34.17% |
| 2002 | 415.37 Thousand USD | -48.42% |
| 2001 | 805.23 Thousand USD | -71.82% |
| 2000 | 2.85 Million USD | -59.57% |
| 1999 | 7.06 Million USD | -39.07% |
| 1998 | 11.6 Million USD | 296.61% |
| 1997 | -5.9 Million USD | -166.29% |
| 1996 | 8.9 Million USD | -33.08% |
| 1995 | 13.3 Million USD | 329.03% |
| 1994 | 3.1 Million USD | 142.47% |
| 1993 | -7.3 Million USD | -21.67% |
| 1992 | -6 Million USD | -42.86% |
| 1991 | -4.2 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -14 Thousand USD | 50.0% |
| 2024 Q1 | -28 Thousand USD | -126.17% |
| 2023 Q1 | -25 Thousand USD | 24.24% |
| 2023 FY | -106 Thousand USD | -3.92% |
| 2023 Q4 | 107 Thousand USD | 635.0% |
| 2023 Q2 | -26 Thousand USD | -4.0% |
| 2023 Q3 | -20 Thousand USD | 23.08% |
| 2022 FY | -102 Thousand USD | -34.21% |
| 2022 Q4 | -33 Thousand USD | -32.0% |
| 2022 Q3 | -25 Thousand USD | -8.7% |
| 2022 Q2 | -23 Thousand USD | -9.52% |
| 2022 Q1 | -21 Thousand USD | 25.0% |
| 2021 FY | -76 Thousand USD | -11.76% |
| 2021 Q1 | -18 Thousand USD | 0.0% |
| 2021 Q2 | -14 Thousand USD | 22.22% |
| 2021 Q3 | -16 Thousand USD | -14.29% |
| 2021 Q4 | -28 Thousand USD | -75.0% |
| 2020 Q1 | - USD | 0.0% |
| 2020 FY | -68 Thousand USD | 19.05% |
| 2020 Q4 | - USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2020 Q2 | - USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 FY | -84 Thousand USD | -55.56% |
| 2019 Q4 | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 FY | -54 Thousand USD | -157.14% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2017 FY | -21 Thousand USD | -110.0% |
| 2017 Q1 | - USD | 100.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2016 Q2 | 29.31 Thousand USD | 26.54% |
| 2016 Q1 | 23.16 Thousand USD | -20.12% |
| 2016 FY | -10 Thousand USD | -110.0% |
| 2016 Q4 | -85.23 Thousand USD | -360.17% |
| 2016 Q3 | 32.76 Thousand USD | 11.77% |
| 2015 FY | 100 Thousand USD | -90.12% |
| 2015 Q2 | 30.13 Thousand USD | 43.5% |
| 2015 Q1 | 20.99 Thousand USD | -96.82% |
| 2015 Q3 | 37.03 Thousand USD | 22.9% |
| 2015 Q4 | 29 Thousand USD | -21.69% |
| 2014 Q4 | 659.46 Thousand USD | 212.54% |
| 2014 Q1 | 252.2 Thousand USD | 11.59% |
| 2014 Q3 | 211 Thousand USD | 28.57% |
| 2014 Q2 | 164.1 Thousand USD | -34.93% |
| 2014 FY | 1.01 Million USD | 14.09% |
| 2013 FY | 887 Thousand USD | -19.71% |
| 2013 Q2 | 204.12 Thousand USD | -6.09% |
| 2013 Q4 | 226 Thousand USD | -5.46% |
| 2013 Q3 | 239.04 Thousand USD | 17.11% |
| 2013 Q1 | 217.35 Thousand USD | 39.31% |
| 2012 Q2 | 185 Thousand USD | -67.66% |
| 2012 FY | 1.1 Million USD | 9.82% |
| 2012 Q4 | 156.02 Thousand USD | -18.78% |
| 2012 Q1 | 572.07 Thousand USD | 15.78% |
| 2012 Q3 | 192.1 Thousand USD | 3.84% |
| 2011 FY | 1 Million USD | -20.07% |
| 2011 Q1 | 167 Thousand USD | -73.71% |
| 2011 Q2 | 182 Thousand USD | 8.98% |
| 2011 Q3 | 163 Thousand USD | -10.44% |
| 2011 Q4 | 494.09 Thousand USD | 203.13% |
| 2010 Q2 | 219.26 Thousand USD | 17.56% |
| 2010 Q3 | 217.6 Thousand USD | -0.76% |
| 2010 Q1 | 186.51 Thousand USD | -47.78% |
| 2010 Q4 | 635.16 Thousand USD | 191.89% |
| 2010 FY | 1.25 Million USD | 72.07% |
| 2009 Q3 | 111.71 Thousand USD | -45.75% |
| 2009 FY | 731.42 Thousand USD | 215.64% |
| 2009 Q1 | 56.6 Thousand USD | -67.12% |
| 2009 Q4 | 357.18 Thousand USD | 219.73% |
| 2009 Q2 | 205.92 Thousand USD | 263.81% |
| 2008 Q4 | 172.16 Thousand USD | 1290.82% |
| 2008 Q3 | 12.37 Thousand USD | -58.5% |
| 2008 Q2 | 29.83 Thousand USD | 71.94% |
| 2008 Q1 | 17.35 Thousand USD | -41.73% |
| 2008 FY | 231.73 Thousand USD | 308.54% |
| 2007 Q2 | 7840.00 USD | 31.85% |
| 2007 Q1 | 5946.00 USD | -52.22% |
| 2007 Q3 | 13.16 Thousand USD | 67.88% |
| 2007 Q4 | 29.77 Thousand USD | 126.21% |
| 2007 FY | 56.72 Thousand USD | -38.91% |
| 2006 FY | 92.85 Thousand USD | -54.91% |
| 2006 Q1 | 41.55 Thousand USD | -2.39% |
| 2006 Q4 | 12.44 Thousand USD | -32.08% |
| 2006 Q3 | 18.32 Thousand USD | -10.78% |
| 2006 Q2 | 20.53 Thousand USD | -50.58% |
| 2005 FY | 205.91 Thousand USD | 46.0% |
| 2005 Q4 | 42.56 Thousand USD | -53.35% |
| 2005 Q3 | 91.25 Thousand USD | 148.18% |
| 2005 Q2 | 36.76 Thousand USD | 4.1% |
| 2005 Q1 | 35.32 Thousand USD | -5.97% |
| 2004 FY | 141.03 Thousand USD | -48.42% |
| 2004 Q2 | 5837.00 USD | -93.73% |
| 2004 Q3 | 4541.00 USD | -22.2% |
| 2004 Q4 | 37.56 Thousand USD | 727.22% |
| 2004 Q1 | 93.09 Thousand USD | -23.31% |
| 2003 Q1 | 58.95 Thousand USD | -33.81% |
| 2003 Q4 | 121.39 Thousand USD | 270.2% |
| 2003 Q3 | 32.79 Thousand USD | -45.62% |
| 2003 FY | 273.43 Thousand USD | -34.17% |
| 2003 Q2 | 60.29 Thousand USD | 2.28% |
| 2002 Q2 | 125.32 Thousand USD | 12.61% |
| 2002 Q4 | 89.06 Thousand USD | -0.69% |
| 2002 Q1 | 111.29 Thousand USD | 903.02% |
| 2002 FY | 415.37 Thousand USD | -48.42% |
| 2002 Q3 | 89.68 Thousand USD | -28.44% |
| 2001 Q1 | 242.55 Thousand USD | -89.17% |
| 2001 Q4 | -13.86 Thousand USD | -105.01% |
| 2001 FY | 805.23 Thousand USD | -71.82% |
| 2001 Q3 | 276.53 Thousand USD | -7.82% |
| 2001 Q2 | 300 Thousand USD | 23.68% |
| 2000 Q2 | 159.43 Thousand USD | -35.76% |
| 2000 Q3 | 209.81 Thousand USD | 31.6% |
| 2000 Q4 | 2.24 Million USD | 967.65% |
| 2000 FY | 2.85 Million USD | -59.57% |
| 2000 Q1 | 248.2 Thousand USD | -46.95% |
| 1999 Q3 | 700 Thousand USD | -77.42% |
| 1999 FY | 7.06 Million USD | -39.07% |
| 1999 Q1 | 3.1 Million USD | -16.22% |
| 1999 Q2 | 3.1 Million USD | 0.0% |
| 1999 Q4 | 467.87 Thousand USD | -33.16% |
| 1998 FY | 11.6 Million USD | 296.61% |
| 1998 Q4 | 3.7 Million USD | 19.35% |
| 1998 Q3 | 3.1 Million USD | 29.17% |
| 1998 Q2 | 2.4 Million USD | 4.35% |
| 1998 Q1 | 2.3 Million USD | 114.29% |
| 1997 FY | -5.9 Million USD | -166.29% |
| 1997 Q4 | -16.1 Million USD | -800.0% |
| 1997 Q3 | 2.3 Million USD | -58.93% |
| 1997 Q2 | 5.6 Million USD | 133.33% |
| 1997 Q1 | 2.4 Million USD | 0.0% |
| 1996 FY | 8.9 Million USD | -33.08% |
| 1996 Q3 | 2.2 Million USD | -4.35% |
| 1996 Q2 | 2.3 Million USD | 9.52% |
| 1996 Q1 | 2.1 Million USD | -12.5% |
| 1996 Q4 | 2.4 Million USD | 9.09% |
| 1995 Q2 | -1.7 Million USD | -125.37% |
| 1995 FY | 13.3 Million USD | 329.03% |
| 1995 Q1 | 6.7 Million USD | 1240.0% |
| 1995 Q4 | 2.4 Million USD | 4.35% |
| 1995 Q3 | 2.3 Million USD | 235.29% |
| 1994 Q2 | 500 Thousand USD | -70.59% |
| 1994 FY | 3.1 Million USD | 142.47% |
| 1994 Q1 | 1.7 Million USD | -19.05% |
| 1994 Q4 | 500 Thousand USD | 0.0% |
| 1994 Q3 | 500 Thousand USD | 0.0% |
| 1993 Q2 | -2.1 Million USD | 4.55% |
| 1993 Q3 | 200 Thousand USD | 109.52% |
| 1993 Q4 | 2.1 Million USD | 950.0% |
| 1993 FY | -7.3 Million USD | -21.67% |
| 1993 Q1 | -2.2 Million USD | -650.0% |
| 1992 Q1 | 200 Thousand USD | 0.0% |
| 1992 FY | -6 Million USD | -42.86% |
| 1992 Q3 | 400 Thousand USD | 0.0% |
| 1992 Q2 | 400 Thousand USD | 100.0% |
| 1992 Q4 | 400 Thousand USD | 0.0% |
| 1991 FY | -4.2 Million USD | 0.0% |
| 1991 Q2 | 100 Thousand USD | 0.0% |
| 1991 Q1 | 100 Thousand USD | 0.0% |
| 1991 Q4 | 200 Thousand USD | 100.0% |
| 1991 Q3 | 100 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 56.3 Million USD | 100.188% |
| AngioDynamics, Inc. | 154.69 Million USD | 100.069% |
| AtriCure, Inc. | 300.37 Million USD | 100.035% |
| Avinger, Inc. | 2 Million USD | 105.292% |
| Azenta, Inc. | 263.14 Million USD | 100.04% |
| BioLife Solutions, Inc. | 46.75 Million USD | 100.227% |
| The Cooper Companies, Inc. | 2.35 Billion USD | 100.004% |
| Daxor Corporation | 1.1 Million USD | 109.606% |
| Ekso Bionics Holdings, Inc. | 9.07 Million USD | 101.168% |
| Femasys Inc. | 691.9 Thousand USD | 115.32% |
| GlucoTrack, Inc. | -13 Thousand USD | -715.385% |
| Harvard Bioscience, Inc. | 60.86 Million USD | 100.174% |
| Hologic, Inc. | 2.22 Billion USD | 100.005% |
| ICU Medical, Inc. | 739.87 Million USD | 100.014% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 100.002% |
| KORU Medical Systems, Inc. | 16.7 Million USD | 100.634% |
| LeMaitre Vascular, Inc. | 127.04 Million USD | 100.083% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 11.17% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 11.17% |
| Masimo Corporation | 1 Billion USD | 100.011% |
| Meihua International Medical Technologies Co., Ltd. | 33.09 Million USD | 100.32% |
| Merit Medical Systems, Inc. | 583.87 Million USD | 100.018% |
| Nephros, Inc. | 8.4 Million USD | 101.261% |
| NovoCure Limited | 381.05 Million USD | 100.028% |
| NEXGEL, Inc. | 619 Thousand USD | 117.124% |
| NEXGEL, Inc. | 619 Thousand USD | 117.124% |
| Singular Genomics Systems, Inc. | -558 Thousand USD | 81.004% |
| OraSure Technologies, Inc. | 179.42 Million USD | 100.059% |
| Pro-Dex, Inc. | 14.55 Million USD | 100.728% |
| Pulse Biosciences, Inc. | -1.2 Million USD | 91.218% |
| Predictive Oncology Inc. | 1.14 Million USD | 109.255% |
| Precision Optics Corporation, Inc. | 5.79 Million USD | 101.828% |
| QuidelOrtho Corporation | 1.49 Billion USD | 100.007% |
| Repligen Corporation | 315.22 Million USD | 100.034% |
| Sanara MedTech Inc. | 57.13 Million USD | 100.186% |
| STAAR Surgical Company | 252.65 Million USD | 100.042% |
| Sharps Technology, Inc. | -891.24 Thousand USD | 88.107% |
| Utah Medical Products, Inc. | 30.03 Million USD | 100.353% |
| DENTSPLY SIRONA Inc. | 2.08 Billion USD | 100.005% |
| Jin Medical International Ltd. | 6.78 Million USD | 101.562% |